PPP2R2B and breast cancer: To further explore the potential mechanisms involved in the anti-oncogenic roles of PPP2R2B in BC progression, we performed western blot and found that overexpression of PPP2R2B suppressed the levels of MMP‐9, β‐catenin and N‐cadherin, while promoting the expression of E‐cadherin (Fig. 9C).